OTCMKTS:BTCY

Biotricity - BTCY Stock Forecast, Price & News

$0.46

-0.02 (-4.17%)

(As of 03/24/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.45
▼
$0.52
50-Day Range: $0.46
▼
$0.88
52-Week Range: $0.40
▼
$2.48

Volume: 183,987 shs
Average Volume: 68,301 shs
Market Capitalization: $24.15 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.00

Institutional Ownership

Headlines

SEC Filings

Short Interest

Biotricity MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 552.2% Upside
$3.00 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.38) to ($0.26) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.75 out of 5 stars

3.3

Analyst's Opinion

Consensus Rating
Biotricity has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $3.00, Biotricity has a forecasted upside of 552.2% from its current price of $0.46.
Amount of Analyst Coverage
Biotricity has only been the subject of 1 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for BTCY.

0.0

Dividend Strength

Dividend Yield
Biotricity does not currently pay a dividend.
Dividend Growth
Biotricity does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for BTCY.

1.3

News and Social Media Coverage

News Sentiment
Biotricity has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Medical companies.
Search Interest
Only 3 people have searched for BTCY on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Biotricity to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Biotricity insiders have not sold or bought any company stock.
Percentage Held by Insiders
20.46% of the stock of Biotricity is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 4.83% of the stock of Biotricity is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Biotricity are expected to grow in the coming year, from ($0.38) to ($0.26) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Biotricity is -1.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Biotricity is -1.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

About Biotricity (OTCMKTS:BTCY) Stock

Biotricity, Inc. is a medical technology company, which is focused on biometric data monitoring solutions. It is also involved in delivering remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. The firm's FDA-approved Bioflux MCT technology is comprised of monitoring device and software components, which are made available to the market to assess, establish and develop sales processes, and market dynamics. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA.

Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

BTCY Stock News Headlines

March 7, 2023 | finance.yahoo.com

Medical Biometric Firm Biotricity Reshaping Market Through Pioneering Innovation

February 16, 2023 | finance.yahoo.com

Biotricity, Inc. (NASDAQ:BTCY) Q3 2023 Earnings Call Transcript

March 26, 2023 | Legacy Research (Affiliate) (Ad)

"Prepare for Five Years of Famine"

Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast

February 16, 2023 | finance.yahoo.com

Biotricity Third Quarter 2023 Earnings: Revenues Beat Expectations

February 14, 2023 | finance.yahoo.com

Biotricity Reports Financial Results for Fiscal 2023 Third Quarter

February 9, 2023 | finance.yahoo.com

Biotricity To Host Fiscal 2023 Third Quarter Financial Results Call on February 14th at 4:30pm ET

February 3, 2023 | finance.yahoo.com

Biotricity Selected to Present its Work on AI Enabled Stroke Prediction in CKD Patients at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference

January 26, 2023 | finance.yahoo.com

Biotricity Signs Distribution Agreement With Top 5 Distributor for its Cardiac Monitoring Solutions

March 26, 2023 | Legacy Research (Affiliate) (Ad)

"Prepare for Five Years of Famine"

Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast

January 23, 2023 | finance.yahoo.com

Biotricity to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th at 8:15 A.M. ET

December 12, 2022 | finance.yahoo.com

Biotricity Files FDA 510(k) for a new Form Factor of its Biotres Cardiac Monitoring Device to Expand its Revenue Growth

December 12, 2022 | finance.yahoo.com

Biotricity Files FDA 510(k) For Expanded Use Of Its Biotres Cardiac Monitoring Device

December 9, 2022 | reuters.com

BTCY.O - Biotricity Inc | Stock Price & Latest News | Reuters

November 16, 2022 | finance.yahoo.com

Biotricity Signs Distribution Agreement to Expand Access for its Cardiac Monitoring Solutions

November 10, 2022 | finance.yahoo.com

Biotricity's Bioheart Named to TIME's List of The Best Inventions of 2022

November 1, 2022 | finance.yahoo.com

Biotricity to Host Fiscal 2023 Second Quarter Financial Results on November 14th at 4:30 PM ET

October 26, 2022 | finance.yahoo.com

Biotricity Launches Cardiac Disease Management Solution Following 2 Successful Pilots with Oklahoma & Kentucky Clinics

October 13, 2022 | finance.yahoo.com

Biotricity CEO, Waqaas Al-Siddiq, to Participate in Panel Discussion on the Evolution of Medical Devices at the American Medical Device Summit on October 19th

October 12, 2022 | businesswire.com

The Global Market for Wearable Electronic Skin Patches 2023-2033 - ResearchAndMarkets.com - Business Wire

October 7, 2022 | finance.yahoo.com

FUKUI COMPUTER Partners with Bentley Systems to Promote Digital Transformation in Japan’s Infrastructure Field - Yahoo Finance

October 7, 2022 | finance.yahoo.com

Shareholders have faith in loss-making Biotricity (NASDAQ:BTCY) as stock climbs 18% in past week, taking three-year gain to 90%

October 4, 2022 | finance.yahoo.com

Biotricity Surpasses 2 billion Recorded and Analyzed Heartbeats for Atrial Fibrillation (AFib)

September 15, 2022 | streetinsider.com

Diagnostic Electrocardiograph Market to hit US$ 14.83 Billion by 2030 | Exclusive Report by Growth Plus Reports - StreetInsider.com

September 7, 2022 | globenewswire.com

Smart Pregnancy Tracker Market is estimated to be US$ 13.2 Billion by 2020 with a CAGR of 17.4% during the forecast period 2030 - By PMI - GlobeNewswire

September 7, 2022 | finance.yahoo.com

Biotricity Wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled Real-Time Monitoring and Predictive Analytics for Stroke due to Chronic Kidney Failure - Yahoo Finance

September 7, 2022 | finance.yahoo.com

Biotricity Wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled Real-Time Monitoring and Predictive Analytics for Stroke due to Chronic Kidney Failure

September 5, 2022 | businesswire.com

Global External Remote Patient Monitoring Devices Pipeline Report 2022: Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies - ResearchAndMarkets.com - Business Wire

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

BTCY Company Calendar

Last Earnings: 2/14/2023
Today: 3/26/2023
Fiscal Year End: 3/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:BTCY
CUSIP: N/A
CIK: 1630113
Web: www.biotricity.com
Phone: (650) 832-1626
Fax: N/A
Employees: 44
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $3.00
High Stock Price Forecast: $4.00
Low Stock Price Forecast: $2.00
Forecasted Upside/Downside: +552.2%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.40)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-29,130,000.00
Net Margins: -220.94%
Pretax Margin: -216.64%
Return on Equity: -6,795.29%
Return on Assets: -183.66%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.66
Quick Ratio: 0.39

Sales & Book Value

Annual Sales: $7.70 million
Price / Sales: 3.14
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.04) per share
Price / Book: -11.50

Miscellaneous

Outstanding Shares: 52,510,000
Free Float: 41,770,000
Market Cap: $24.15 million
Optionable: Not Optionable
Beta: 2.44

Key Executives

Waqaas Al-Siddiq
Chairman, President & Chief Executive Officer

John Ayanoglou
Chief Financial Officer

Spencer LaDow
Vice President-Engineering

Amir Ali
Chief Development Officer

Key Competitors

View All Competitors

Institutional Ownership

Simplex Trading LLC
Bought 400 shares on 2/2/2023
Ownership: 0.000%

View All Institutional Transactions

BTCY Stock - Frequently Asked Questions

Should I buy or sell Biotricity stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biotricity in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" BTCY shares.
View BTCY analyst ratings or view top-rated stocks.
What is Biotricity's stock price forecast for 2023?: 2 brokerages have issued 12 month price targets for Biotricity's stock. Their BTCY share price forecasts range from $2.00 to $4.00. On average, they expect the company's stock price to reach $3.00 in the next year. This suggests a possible upside of 552.2% from the stock's current price.
View analysts price targets for BTCY or view top-rated stocks among Wall Street analysts.
How have BTCY shares performed in 2023?: Biotricity's stock was trading at $0.4480 at the beginning of the year. Since then, BTCY stock has increased by 2.7% and is now trading at $0.46.
View the best growth stocks for 2023 here.
How were Biotricity's earnings last quarter?: Biotricity, Inc. (OTCMKTS:BTCY) announced its earnings results on Tuesday, February, 14th. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.09). The company had revenue of $2.46 million for the quarter, compared to the consensus estimate of $2.80 million. Biotricity had a negative trailing twelve-month return on equity of 6,795.29% and a negative net margin of 220.94%.
What other stocks do shareholders of Biotricity own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Biotricity investors own include Axsome Therapeutics (AXSM), Bank of America (BAC), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Broadcom (AVGO), Cannabix Technologies (BLOZF), BioLineRx (BLRX), CV Sciences (CVSI) and Charlotte's Web (CWBHF).

What is Biotricity's stock symbol?: Biotricity trades on the OTCMKTS under the ticker symbol "BTCY."
Who are Biotricity's major shareholders?: Biotricity's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends.
How do I buy shares of Biotricity?: Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Biotricity's stock price today?: One share of BTCY stock can currently be purchased for approximately $0.46.
How much money does Biotricity make?: Biotricity (OTCMKTS:BTCY) has a market capitalization of $24.15 million and generates $7.70 million in revenue each year. The company earns $-29,130,000.00 in net income (profit) each year or ($0.40) on an earnings per share basis.
How can I contact Biotricity?: The official website for the company is www.biotricity.com. The company can be reached via phone at (650) 832-1626 or via email at investors@biotricity.com.

This page (OTCMKTS:BTCY) was last updated on 3/26/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Biotricity - BTCY Stock Forecast, Price & News

Biotricity MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Biotricity (OTCMKTS:BTCY) Stock

BTCY Stock News Headlines

BTCY Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

BTCY Stock - Frequently Asked Questions

Overall MarketRank^™